why novartis� landmark cancer drug approval is great news for bluebird.
suven life sciences' pashamylaram facility successfully completes usfda inspection
.
.
..
.
�this negligence must not be allowed to continue,� budkie�s letter states. �the university of california, berkeley, has clearly failed to follow federal regulations and guidelines.�.